4.3.6 - Neural and hormonal control of eating behaviour

Neural and hormonal signals

The brain combines neural and hormonal information to regulate hunger, appetite and satiety.

Eating behaviour has a homeostatic side because the body needs enough energy to survive but cannot eat continuously. The brain receives information about short-term energy availability, such as whether the stomach is empty and whether blood glucose is changing. It also receives longer-term information about energy stores, especially body fat. Those signals affect whether a person experiences hunger, searches for food, feels full and stops eating.

This lesson does not claim that biology is the only reason people eat. Students eat because it is lunch break, because friends are eating, because food is available, or because a snack is rewarding. The AQA point asks for the biological control system, so the AO1 focus is the hypothalamus, ghrelin and leptin. The AO3 focus is whether that system is enough to explain real-world eating.

The hypothalamus is central because it links the nervous system and endocrine system. It can receive neural and hormonal information, then influence appetite, autonomic activity and hormone release. The important point is coordination: signals change the activity of appetite-related circuits rather than issuing an irresistible command to eat or stop.

AO2 example: Liam skips breakfast and by late morning feels hungry, distracted and motivated to buy food. A biological explanation would say that his body is sending hunger signals to the hypothalamus. If he then eats a meal and feels full, satiety signals are now dominating the same control system.

The hypothalamus

The classic A-level account is the dual-centre model. It describes two hypothalamic areas with different roles: the lateral hypothalamus is associated with hunger and feeding, while the ventromedial hypothalamus is associated with satiety and stopping eating.

In the simplified model, falling energy availability activates hunger pathways linked with the LH. One appetite-stimulating chemical often linked to this route is neuropeptide Y.

When hunger pathways are active, the person is motivated to seek and eat food. After eating, satiety pathways become more active. The VMH and related hypothalamic systems help inhibit feeding and support the feeling of fullness. The classic contrast is:

Classic lesion evidence supports this model. Hetherington and Ranson (1942) reported that hypothalamic lesions in rats affected food intake and body weight, helping establish the idea that hypothalamic damage can disrupt normal satiety. Brobeck, Tepperman and Long (1943) gave stronger evidence that ventromedial hypothalamic lesions produced overeating in rats. Anand and Brobeck (1951) later showed that bilateral lesions of the lateral hypothalamus could produce aphagia, a severe reduction or absence of eating. Together, these animal studies support the idea that different hypothalamic areas contribute differently to eating control.

The model is useful, but it is too simple if treated as the whole truth. Current appetite research points to wider hypothalamic circuits, including the arcuate nucleus, and to many interacting gut and fat-tissue signals. A strong AQA answer can still use LH and VMH, but should phrase them as parts of a broader system rather than literal buttons.

AO2 example: If a rat with damage around the VMH keeps eating beyond normal fullness, the dual-centre model would explain this as loss of satiety control. If a rat with bilateral LH damage stops eating, the model would explain this as disruption of feeding pathways.

Ghrelin

Ghrelin is the named hormone most closely associated with hunger.

Ghrelin gives the brain short-term information about meal timing. When the stomach is empty and the person has not eaten for a while, ghrelin levels rise. Ghrelin acts on the hypothalamus, especially pathways involving the arcuate nucleus, and can increase activity in appetite-stimulating systems such as NPY. After eating, ghrelin levels usually fall, so the hunger signal is reduced. Meal anticipation and nutrients also influence ghrelin; an empty stomach is not an exact on/off test for this hormone.

This means ghrelin is not simply a "stomach rumble". It is a blood-borne signal that helps tell the brain that food intake may be needed. Ghrelin therefore links a body signal to neural appetite pathways; it should not be described as being made by the LH or as acting on one isolated hunger button.

Wren et al. (2001) provide useful human evidence. In a randomised double-blind crossover study, nine healthy volunteers received either intravenous ghrelin or saline. They later experienced the other condition. During ghrelin infusion, every participant consumed more energy from a free-choice buffet, with a mean increase of about 28% compared with saline. Appetite ratings were also higher. This supports ghrelin's role as an appetite stimulant in humans, not just in animal research.